Time | Nonincentivized Group | Incentivized Group | P* | ||
---|---|---|---|---|---|
Total Charts Reviewed (n) | Charts Meeting Criterion (n [%]) | Total Charts Reviewed (n) | Charts Meeting Criterion (n [%]) | ||
2003 | |||||
1st quarter | 571 | 518 (90.72) | 651 | 603 (92.63) | .366 |
2nd quarter | 134 | 121 (90.30) | 535 | 479 (89.53) | .545 |
3rd quarter | 392 | 359 (91.58) | 638 | 579 (90.75) | .588 |
4th quarter | 615 | 575 (93.50) | 669 | 609 (91.03) | .227 |
2004 | |||||
1st quarter | 242 | 222 (91.74) | 268 | 253 (94.40) | .985 |
2nd quarter | 223 | 211 (94.62) | 298 | 281 (94.30) | .796 |
3rd quarter | 224 | 210 (93.75) | 301 | 281 (93.36) | .668 |
4th quarter | 114 | 109 (95.61) | 153 | 144 (94.12) | .494 |
2005 | |||||
1st quarter | 267 | 256 (95.88) | 370 | 359 (97.03) | .552 |
2nd quarter | 339 | 300 (88.50) | 421 | 405 (96.20) | .002 |
3rd quarter | 338 | 300 (88.76) | 429 | 418 (97.44) | .011 |
4th quarter | 299 | 272 (90.97) | 369 | 363 (98.37) | .0008 |
2006 | |||||
1st quarter | 314 | 281 (89.49) | 404 | 398 (98.51) | <.0001 |
2nd quarter | 350 | 324 (92.57) | 414 | 401 (96.86) | .048 |
3rd quarter | 344 | 313 (90.99) | 422 | 410 (97.16) | .026 |
4th quarter | 288 | 258 (89.58) | 192 | 184 (95.83) | .196 |
2007 | |||||
1st quarter | 272 | 251 (92.28) | 363 | 343 (94.49) | .463 |
2nd quarter | 350 | 326 (93.14) | 448 | 428 (95.54) | .260 |
3rd quarter | 350 | 339 (96.86) | 420 | 403 (95.95) | .600 |
4th quarter | 250 | 240 (96.00) | 279 | 273 (97.85) | .288 |
No difference was found between nonincentivized and incentivized before 2nd quarter 2005, whereas incentivized had a higher percent of meeting mammography criterion from 2nd quarter 2005 to 3rd quarter 2006 (P < .05 for all); no difference was found in 2007.
* Within-clinic clustering adjusted.